Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...

In January 2018, the Indian government appointed Shanghvi to the Reserve Bank of India's 21-member central board committee. He was awarded Padma Shri in 2016 by the Government of India. Brands ...

But Dilip Shanghvi, 67, is no ordinary man. The child poring through medicine labels decided one fine day to make medicines himself, and became successful, way beyond probably what he himself ...

In 2015, the chairman of Sun Pharma Dilip Shanghvi had briefly dethroned Mukesh Ambani to become the country’s richest man. His response to that was, “I am not comfortable.” Though he doesn ...

Sharing details of Sun Pharma's mergers and acquisitions (M&As) and strategic partnerships, Dilip Shanghvi said, "We are currently in the process of integrating Concert Pharmaceuticals that we ...